Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

After watching this poor performance for 6 months now, almost 7, and given the fact that March 24th has come and gone with no hint of upward movement north of $2.00, I have come to believe that $3.00 is exceedingly unlikely in 2014 and perhaps ever again. The company has flubbed up since the woefully wasteful GE loan and toxic Crede deal and made it worse by misleading their investors that Crede paid 2.84 per unit, when in fact, 2.11 was the correct figure.

The short interest is so big, it makes me wonder if the biggest short/s have known for years in advance that a PR is coming someday that the company has abandoned RIGS altogether or that the FDA will reverse itself on the approval of Lymphoseek. If neither of these terrible events ever happen, something huge and negative could seemingly be on the horizon this year (or the shorts would have covered between 1.13 and 2.00). No huge kick in the face comparable to these two potential scenarios will surprise me in 2014 or 2015. I used to believe in this company. A huge surprise to me is that no shareholder lawsuits have been filed since we hit 1.13 and have struggled to be a 2.00 stock. I think they could come - and the company seems not to give a damn.

I have always said with NAVB, "Expect the unexpected." Well, I never expected any decline to last like this and become permanent as we see no evidence of a real turnaround. Why did the pps get pushed up to 2.00 yesterday? The company let a few folks know that a PR was coming out today so that they could buy up shares and flip them above 2.00. Unfortunately for the unlucky buyers after 2PM yesterday, the pps is back to sub-garbage levels now.

I want to know what the significance of the Celgene Board member is. Enough of the bleeding and suffering - sell the company!

MAJOR MANAGEMENT CHANGES ARE NEEDED and would probably turn this situation around quite rapidly. If only.